Vol. 20 No. 3 (2016)
REVIEWS

Myocardial revascularization in patients with multivessel coronary lesions

PDF (Русский)
  • L Kalugina,
  • I Urvantseva
L Kalugina
District Cardiological Dispensary — Centre for Diagnostics and Cardiovascular surgery, 628400 Surgut, Russian Federation; Surgut State University, 628412 Surgut, Russian Federation
Bio
I Urvantseva
District Cardiological Dispensary — Centre for Diagnostics and Cardiovascular surgery, 628400 Surgut, Russian Federation; Surgut State University, 628412 Surgut, Russian Federation
Bio
DOI: https://doi.org/10.21688/1681-3472-2016-3-14-19

Published 2016-11-10

Keywords

  • coronary heart disease,
  • myocardial revascularization,
  • endovascular surgery,
  • multivessel coronary disease

How to Cite

Kalugina, L., & Urvantseva, I. (2016). Myocardial revascularization in patients with multivessel coronary lesions. Patologiya Krovoobrashcheniya I Kardiokhirurgiya, 20(3), 14–19. https://doi.org/10.21688/1681-3472-2016-3-14-19

Copyright (c) 2016 Kalugina L.S., Urvantseva I.A.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Abstract

The review is devoted to one of the challenges in coronary surgery — revascularization for multivessel lesions. Emphasis is placed on the results of retrospective and prospective studies on the efficacy and safety of different types of coronary surgery. The data of modern literature concerning the extent of operative intervention and the options for elimination and prevention of restenosis in the lumen of a stent are analyzed.

Received 11 July 2016. Accepted 31 August 2016.

Funding: The study had no sponsorship.
Conflict of interest: The authors declare no conflict of interest.
Acknowledgments
The authors thank the members of Cardiology Department at Surgut State University and the employees of Okrug Cardiology Dispensary of Khanty-Mansi Autonomous Okrug for assistance in article preparation.

PDF (Русский)

References

  1. Danchin N, Angioi M, Rodriguez R. Angioplasty in chronic coronary occlusion. Arch mal Coeur Vaiss. 1999;99(suppl. 11):1657-1660.
  2. Meier B, Luethy P, Finci L, Steffenino GD, Rutishauser W. Coronary wedge pressure in relation to spontaneously visible and recruitable collaterals. Circulation. 2008;75(5):906-913.
  3. Safley DM, House JA, Marso SP, Grantham JA, Rutherford BD. Improvement in survival following successful percutaneous coronary intervention of coronary chronic total occlusions: variability by target vessel. JACC Cardiovasc Interv. 2008;1(3):295-302.
  4. Babunashvili AM, Ivanov VA. Hronicheskie okklyuzii koronarnyh arterij: anatomiya, patofi ziologiya, ehndovaskulyarnoe lechenie. Moscow, ASV Publ., 2012. 90 p. (In Russ.).
  5. Prasad A, Rihal CS, Lennon RJ, Wiste HJ, Singh M, Holmes DR Jr. Trends in outcomes after percutaneous coronary intervention for chronic total occlusions: a 25-year experience from the Mayo Clinic. J Am Coll Cardiol. 2007;49(15):1611-1618.
  6. King SB 3rd, Kosinski AS, Guyton RA, Lembo NJ, Weintraub WS. Eight-year mortality in the Emory Angioplasty versus Surgery Trial (EAST). J Am Coll Cardiol. 2000;35(5):1116-1121.
  7. Hlatky MA, Rogers WJ, Johnstone I, Boothroyd D, Brooks MM, Pitt B, Reeder G, Ryan T, Smith H, Whitlow P, Wiens R, Mark DB, Rosen AD, Detre K, Frye RL, for the Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Medical care costs and quality of life after randomization to coronary angioplasty or coronary bypass surgery. N Engl J Med. 1997;336(2):92-99.
  8. Detre KM, Lombardero MS, Brooks M.M., Hardison R.M., Holubkov R., Sopko G., Frye R.L., Chaitman B.R. The effect of previous coronary-artery bypass surgery on the prognosis of patients with diabetes who have acute myocardial infarction. Bypass Angioplasty Revascularization Investigation Investigators. N Engl J Med. 2000;342(14):989-997.
  9. Booth J, Clayton T, Pepper J, Nugara F, Flather M, Sigwart U, Stables RH, SoS Investigators. Randomized, controlled trial of coronary artery bypass surgery versus percutaneous coronary intervention in patients with multivessel coronary artery disease: six-year follow-up from the Stent or Surgery Trial (SoS). Circulation. 2008;118(4):381-388.
  10. Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ, Ståhle E, Feldman TE, van den Brand M, Bass EJ, Van Dyck N, Leadley K, Dawkins KD, Mohr FW; SYNTAX Investigators. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009;360(10):961-972.
  11. Mohr FW, Morice MC, Kappetein AP, Feldman TE, Ståhle E, Colombo A, Mack MJ, Holmes DR Jr, Morel MA, Van Dyck N, Houle VM, Dawkins KD, Serruys PW. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet. 2013;381(9867):629-638.
  12. Hueb W, Lopes N, Gersh BJ, Soares PR, Ribeiro EE, Pereira AC, Favarato D, Rocha AS, Hueb AC, Ramires JA. Ten-year follow-up survival of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation. 2010;122(10):949-957.
  13. Takagi H, Yamamoto H, Iwata K, Goto SN, Umemoto T; ALICE (All-Literature Investigation of Cardiovascular Evidence) Group. Drug-eluting stents increase late mortality compared with coronary artery bypass grafting in triple-vessel disease: a meta-analysis of randomized controlled and risk-adjusted observational studies. Int J Cardiol. 2012;159(3):230-233.
  14. Wijns W, Kolh P, Danchin N. et al. Guidelines on myocardial revascularization. Eur Heart J. 2010;31(20):2501-2555.
  15. Hillis LD, Smith PK, Anderson JL et al. 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, Society of Cardiovascular Anesthesiologists, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2011;58(24):e123-210.
  16. Coronary Revascularization Writing Group, Patel MR, Dehmer GJ, Hirshfeld JW et al. ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 appropriate use criteria for coronary revascularization focused update: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, American Society of Nuclear Cardiology, and the Society of Cardiovascular Computed Tomography. J Thorac Cardiovasc Surg. 2012;143(4):780-803.
  17. Corpus RA, House JA, Marso SP, Grantham JA, Huber KC Jr, Laster SB, Johnson WL, Daniels WC, Barth CW, Giorgi LV, Rutherford BD. Multivessel percutaneous coronary intervention in patients with multivessel disease and acute myocardial infarction. Am Heart J. 2004;148(3):493-500.
  18. Meliga E, Fiorina C, Valgimigli M, Belli R, Gagnor A, Sheiban I, Resmini C, Tizzani E, Aranzulla T, Scrocca I, DE Benedictis M, Conte MR. Early angio-guided complete revascularization versus culprit vessel PCI followed by ischemia-guided staged PCI in STEMI patients with multivessel disease. J Interv Cardiol. 2011;24(6):535-541.
  19. Vlaar PJ, Mahmoud KD, Holmes DR Jr, van Valkenhoef G, Hillege HL, van der Horst IC, Zijlstra F, de Smet BJ. Culprit vessel only versus multivessel and staged percutaneous coronary intervention for multivessel disease in patients presenting with ST-segment elevation myocardial infarction: a pairwise and network meta-analysis. J Am Coll Cardiol. 2011;58(7):692-703.
  20. Politi L, Sgura F, Rossi R, Monopoli D, Guerri E, Leuzzi C, Bursi F, Sangiorgi GM, Modena MG. A randomised trial of target-vessel versus multi-vessel revascularisation in ST-elevation myocardial infarction: major adverse cardiac events during long-term follow-up. Heart. 2010;96(9):662-667.
  21. Hannan EL, Samadashvili Z, Walford G. Culprit vessel percutaneous coronary intervention versus multivessel and staged percutaneous coronary intervention for ST-segment elevation myocardial infarction patients with multivessel disease. JACC Cardiovasc Interv. 2010;3(1):22-31.
  22. Bosch X., Marrugat J., Sanchis J. Platelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non-ST segment elevation acute coronary syndromes. Cochrane Database Syst Rev. 2013. (11): CD002130.
  23. Xu X, Zhang W, Zhou Y, Zhao Y, Liu Y, Shi D, Zhou Z, Ma H, Wang Z, Yu M, Ma Q, Gao F, Shen H, Zhang J. Effect of trimetazidine on recurrent angina pectoris and left ventricular structure in elderly multivessel coronary heart disease patients with diabetes mellitus after drug-eluting stent implantation: a single-centre, prospective, randomized, double-blind study at 2-year follow-up. Clin Drug Investig. 2014;34(4):251-8.
  24. Wohrle J, Krause BJ, Nusser T, Kochs M, Hoher M. Repeat intracoronary beta-brachytherapy using a rhenium-188-filled balloon catheter for recurrent restenosis in patients who failed intracoronary radiation therapy. Cardiovasc Revasc Med. 2006;7(1):2-6.
  25. Eisenberg MJ, Konnyu KJ. Review of randomized clinical trials of drug-eluting stents for the prevention of in-stent restenosis. Am J Cardiol. 2006;98(3):375-382.
  26. Akin I, Schneider H, Ince H, Kische S, Rehders TC, Chatterjee T, Nienaber CA. Second- and third-generation drug-eluting coronary stents: progress and safety. Herz. 2011;36(3):190-196.
  27. Kalugina LS, Urvantseva IA. Myocardial revascularization in multivessel coronary lesions in conjunction with chronic occlusion. Choosing tactics. Ateroskleroz. 2015;11(4):74-82. (In Russ.).